The composition of the gut microbiomes in a group of rectal cancer patients reveals distinct signatures by race, ethnicity, and age of onset, with white Hispanics showing significant presence of one specific type of bacteria, UT Southwestern Medical Center researchers report.
FDA approved Elahere (mirvetuximab soravtansine-gynx) for adult patients with FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received one to three prior systemic treatment regimens.
FDA granted HDP-101 orphan drug designation in multiple myeloma.
The FDA Oncologic Drugs Advisory Committee voted overwhelmingly in favor of expanding the indications of two chimeric antigen receptor engineered T-cell therapies for multiple myeloma that showed improvement in progression-free survival, but also reported a higher number of early deaths on the experimental arm.
Addressing the NCI Board of Scientific Advisors, Institute Director Kimryn Rathmell announced two key initiatives—the Cancer Screening Research Network and the Virtual Clinical Trials Office—designed to achieve large reductions in cancer mortality and support the cancer research enterprise.
U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.
ASCO and Conquer Cancer, the ASCO Foundation, will recognize researchers, patient advocates, philanthropists, teachers, and global oncology leaders at the 2024 ASCO Annual Meeting.
Brian DrukerTom SellersAfter serving as the OHSU Knight Cancer Institute’s director for more than 17 years, Brian Druker will take on a new role as the institute’s chief executive officer.
Melissa L. Bondy, chair in the Department of Epidemiology and Population Health at Stanford School of Medicine, received the Joseph F. Fraumeni, Jr. Distinguished Achievement Award from the American Society of Preventive Oncology in Chicago last week.
Matthew Carpenter, co-leader of the Cancer Control Research Program at MUSC Hollings Cancer Center and the Flora McLeod Edwards Distinguished Endowed Chair in Cancer Research, received the Joseph W. Cullen Memorial Award from the American Society of Preventive Oncology in Chicago last week.
